New drug GEn-1124 tested for severe lung failure
Disease control
Recruiting now
This study tests a new drug called GEn-1124 in 52 adults with acute respiratory distress syndrome (ARDS), a severe lung condition. The drug is given as an IV infusion twice daily for 5 days, starting as soon as possible after diagnosis. The main goal is to check if the drug is sa…
Phase: PHASE2 • Sponsor: GEn1E Lifesciences • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC